Diabetes and Stroke Prevention: A ReviewReportar como inadecuado




Diabetes and Stroke Prevention: A Review - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Stroke Research and TreatmentVolume 2012 2012, Article ID 673187, 6 pages

Review Article

Geriatric Medicine, University of Cardiff, Cardiff CF14 4XY, UK

Department of Internal Medicine, Hospital de la Merced, University of Seville, Seville, Spain

Department of Neurology, Hospital de Valme, University of Seville, Seville, Spain

Department of Internal Medicine, Hospital Clinic, University of Barcelona, Barcelona, Spain

Received 21 May 2012; Revised 19 September 2012; Accepted 25 October 2012

Academic Editor: Graham S. Venables

Copyright © 2012 Jonathan Hewitt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Stroke and diabetes mellitus are two separate conditions which share multiple common threads. Both are increasing in prevalence, both are diseases which affect blood vessels, and both are associated with other vascular risk factors, such as hypertension and dyslipidemia. Abnormal glucose regulation, of which diabetes is one manifestation, is seen in up to two-thirds of people suffering from an acute stroke. Surprisingly, aggressive management of glucose after an acute stroke has not been shown to improve outcome or reduce the incidence of further strokes. More encouragingly, active management of other cardiovascular risk factors has been demonstrated to prevent stroke disease and improve outcome following a stroke in the diabetic person. Hypertension should be treated with a target of 140-80 mmHg, as a maximum. The drug of choice would be an ACE inhibitor, although the priority is blood pressure reduction regardless of the medication chosen. Lipids should be treated with a statin whatever the starting cholesterol. Antiplatelet treatment is also essential but there are no specific recommendations for the diabetic person. As these conditions become more prevalent it is imperative that the right treatment is offered for both primary and secondary prevention in diabetic people, in order to prevent disease and minimize disability.





Autor: Jonathan Hewitt, Luis Castilla Guerra, María del Carmen Fernández-Moreno, and Cristina Sierra

Fuente: https://www.hindawi.com/



DESCARGAR PDF




Documentos relacionados